An acute remission of Reiter's syndrome in male patients treated with bromocriptine.

Abstract

We describe 4 male patients with Reiter's syndrome treated with bromocriptine. All 4 had infectious gastroenteritis and chronic Reiter's syndrome with arthritis and enthesopathy that persisted despite treatment in 3 with antiinflammatory drugs and 1 with sulfasalazine for long periods. In all patients treatment was cancelled 8 days before bromocriptine treatment. In 2 patients a dramatic improvement was observed 24 h after 2.5 mg/day of bromocriptine. Two patients improved after 4 days of bromocriptine treatment (5 mg/day). All 4 patients remained asymptomatic for at least 4 months of bromocriptine treatment. Bromocriptine may be useful for treating male patients with Reiter's syndrome.

• Authors: G Bravo, B Zazueta, C Lavalle
• Journal: The Journal of rheumatology (J Rheumatol) Vol. 19 Issue 5 Pg. 747-50 (May 1992) ISSN: 0315-162X [Print] Canada
• PMID: 1351943 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Bromocriptine
• Sulfasalazine

Topics

• Adult
• Arthritis, Reactive (complications, drug therapy)
• Bromocriptine (therapeutic use)
• Dose-Response Relationship, Drug
• Gastroenteritis (complications, drug therapy)
• Humans
• Male
• Remission Induction
• Sulfasalazine (therapeutic use)